MercadoLibre (NASDAQ: MELI), the largest online commerce ecosystem in Latin America, has seen its shares soar more than 75% in 2020. Due to its sole focus on providing e-commerce and digital payments services, the company has benefited tremendously from the coronavirus pandemic
Investors seem to be spooked by the resurgence in coronavirus cases as they fear that another round of business restrictions and lockdown measures might derail the economic recovery achieved so far. The coronavirus crisis continues to be acute in the United States, as the death
This week, Netflix (NASDAQ: NFLX) will help kick off earnings season. The streaming media company is slated to report its second-quarter results on Thursday, making it one of the first megacap stocks to report earnings for the second calendar quarter of 2020.
Earlier this year, JetBlue Airways (NASDAQ: JBLU) announced plans to shrink its footprint in its smallest focus city: Long Beach, California. The airline -- which operated up to 35 daily departures there just two years ago -- had already retrenched in the fall of 2018, cutting a
Chipotle (NYSE: CMG) initially moved higher in early Thursday trading before closing lower as a prominent analyst upgraded the consumer discretionary stock. The stock has staged a dramatic turnaround from earlier in the year when shares fell 50%. At that time, investors were fle
Social Security isn't designed to sustain retirees without other income. Those benefits pay the average senior around $1,500 a month, or $18,000 a year, and for many older Americans, that's not enough income. It's for this reason that workers today are encouraged to save indepen
Stocks rose last week, as both the Dow Jones Industrial Average (DJINDICES: ^DJI) and the S&P 500 (SNPINDEX: ^GSPC) edged closer to positive territory for the year. Just a few days into the second half of 2020, the Dow is lower by 9% while the S&P is only down about 2%.
The short answer is General Electric (NYSE: GE) will almost certainly be in a better place in the next five years. However, that doesn't necessarily mean the stock is a buy right now, because a lot of things need to go right for the company to be a good value. Let's take a look
The second quarter earnings season of 2020 is finally here. One way or another, the list of concerns the market has had regarding the devastation the coronavirus pandemic had on corporate profits will be realized.
Social Security benefits are a major source of income for millions of retirees, with around one in five married couples depending on their benefits for at least 90% of their income in retirement, according to the Social Security Administration (SSA).
Investing in growth stocks can enhance your portfolio. These stocks tend to be more popular than plain old dividend stocks because growing businesses also tend to rise in value. Plus, the capital appreciation you can gain from investing in a top growth stock can often be much mo
Millions of Americans have lost their jobs in the wake of COVID-19. Thankfully, unemployment benefits are available to workers who are out of a job through no fault of their own, but sometimes, the rules around claiming them can be a barrier to financial help.
(RTTNews) - German Energy Company E.ON (EONGY.PK) agreed to sell innogy SE's entire electricity and gas retail business in the Czech Republic, innogy Ceska republika, to MVM Group for an undisclosed amount.
Johnson & Johnson (NYSE: JNJ) has been a leader in the pharmaceutical industry for over 130 years. With a vast product portfolio and a 2.8% dividend yield, the stock remains popular with income investors despite a history of modest year-over-year gains. The company experienc
Though many COVID-19 drug and vaccine trials are under way today, there's no guarantee that they will be successful in the next year (or longer). Meanwhile, the long pandemic could also have huge, lasting effects, harming many industries, while also boosting the stocks of certai
(RTTNews) - Tesla has reduced price of its Model Y crossover by $3,000, following a decline in auto demand during the coronavirus-induced lockdowns, according to several reports. The price reduction came just four month after its launch.
The past decade has seen the rise of numerous automated investment management platforms -- "robo advisors" -- that are said to threaten the very existence of the human advice industry. While these services provide core offerings that can and do act as portfolio centerpieces, aut
Investing in clinical-stage biotech companies can lead to market-beating gains in the long run. And speaking of market-beating gains, Moderna (NASDAQ: MRNA) and Inovio Pharmaceuticals (NASDAQ: INO) are two biotechs that have been outperforming the market all year long.